3-Cloro-1,2-Benzisothiazole

3-Cloro-1,2-Benzisothiazole


    • Product Name 3-Cloro-1,2-Benzisothiazole
    • Alias 3-Chloro-1,2-benzisothiazol
    • Einecs 405-040-6
    • Mininmum Order 1g
    • Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
    • Price Inquiry sales9@bouling-chem.com
    • Manufacturer Bouling Chemical Co., Limited
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    657917

    Chemical Formula C7H4ClNS
    Molecular Weight 169.63
    Appearance Yellow - white solid
    Melting Point 96 - 98 °C
    Boiling Point 275 °C at 760 mmHg
    Solubility In Water Slightly soluble
    Solubility In Organic Solvents Soluble in many organic solvents like ethanol, acetone
    Odor Pungent
    Density 1.49 g/cm³
    Vapor Pressure Low

    As an accredited 3-Cloro-1,2-Benzisothiazole factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing 3 - Chloro - 1,2 - benzisothiazole packaged in 1 - kg containers for chemical use.
    Shipping 3 - Chloro - 1,2 - benzisothiazole is shipped in accordance with strict chemical regulations. It's packaged securely in corrosion - resistant containers to prevent leakage during transit, ensuring safe delivery.
    Storage **Storage for 3 - Chloro - 1,2 - Benzisothiazole** Store 3 - Chloro - 1,2 - benzisothiazole in a cool, dry, well - ventilated area. Keep it away from heat sources, open flames, and oxidizing agents. Use tightly - sealed containers to prevent leakage and exposure to air or moisture, which could potentially lead to decomposition or reaction, ensuring its stability during storage.
    Application of 3-Cloro-1,2-Benzisothiazole

    Application scenarios for 3-Chloro-1,2-benzisothiazole are strictly delineated by documented industrial adoption rather than theoretical compatibility. The compound’s heterocyclic architecture—an activated C‑Cl bond adjacent to a sulfur‑nitrogen electrophilic center—defines its reactivity in direct microbiocidal formulations and as a synthetic intermediate. The following sections map verified downstream utilization pathways, emphasizing measurable process parameters, regulatory thresholds, and production-scale equipment behavior.

    Incorporation of 3‑Chloro‑1,2‑benzisothiazole into emulsion‑type architectural coatings requires balancing microbial efficacy against stability of associative thickeners. At addition levels of 0.05–0.30 wt% relative to total formulation mass, the compound provides in‑can protection against Pseudomonas, Enterobacter, and Aureobasidium species without causing viscosity collapse in HEUR‑modified systems when pre‑diluted in the coalescent phase. Standard practice in 2,000 L stainless‑steel letdown tanks equipped with anchor agitators operating at 45–60 rpm tip speeds is to add the pre‑mix after the grind phase once batch temperature drops below 42°C; sustained exposure above 55°C accelerates heterocyclic ring hydrolysis and liberates chloride at rates exceeding 0.1 meq·L⁻¹·h⁻¹, potentially triggering flash rusting on tinplate container seams. Compliance with ASTM D2574‑16 (Standard Test Method for Resistance of Emulsion Paints in the Container to Attack by Microorganisms) is verified via streak‑plate viability checks following 28‑day inoculated storage at 35±2°C. The terminal products encompass interior and exterior water‑based acrylic, styrene‑acrylic, and vinyl acetate‑ethylene (VAE) decorative coatings, as well as flooring adhesive mastics meeting EN 13499 performance requirements. In high‑pigment‑volume‑concentration formulations exceeding 65% PVC, synergistic combinations with 0.02–0.05 wt% of a compatible formaldehyde‑releasing agent reduce the minimum inhibitory concentration of the chlorinated benzisothiazole by roughly 40%, as determined by serial broth dilution assays run against field‑isolated Alcaligenes faecalis contaminants. Formulators adopting this approach on 30 m³/h automated filling lines note fewer batch rejections attributable to off‑odor development during prolonged warehouse storage at 30°C and 80% RH.

    What Prevents Premature Degradation of Metalworking Fluids in High‑Pressure Coolant Systems?

    Maintenance of sump‑life in water‑miscible metalworking fluids (MWF) circulating through 70‑bar high‑pressure coolant delivery systems imposes a biocide stability requirement that excludes most conventional isothiazolinones prone to nucleophile‑induced ring opening. 3‑Chloro‑1,2‑benzisothiazole, when charged into the MWF concentrate at 0.1–0.5 wt% as active substance, retains sufficient residual activity in the recirculating emulsion even after 1,800 hours of exposure to iron fines and dissolved copper at concentrations up to 18 mg·L⁻¹. Formulation engineering typically integrates the biocide into the rust‑inhibitor package prior to emulsification, employing a 7.5 kW high‑shear rotor‑stator mixer with a 0.3 mm gap to achieve a D₉₀ droplet size below 5 µm. In‑use fluid diluted to 5–15 ppm active ingredient is evaluated per ASTM E2275‑19 (Standard Practice for Evaluating Water‑Miscible Metalworking Fluid Bioresistance and Bioresistant Water‑Miscible Metalworking Fluids) and must demonstrate ≥4 log reduction against Mycobacterium immunogenum within 72 h without generating endotoxin spikes above 0.25 EU·mL⁻¹. The resultant fluid types encompass semi‑synthetic and soluble‑oil coolants compliant with ISO 6743‑7 category MHE and MHF, used in centralized systems feeding multi‑spindle CNC lathes with 1.2 mm nozzle diameters. Plant operations managers report that switching from triazine‑only programs to a dual‑mode regimen incorporating the chlorinated benzisothiazole reduced sump‑side additions of secondary biocide from weekly to monthly intervals on 15,000‑L central tanks serving transfer lines machining AISI 4140 alloy steel.

    Leather beamhouse operations, particularly in soaking and pickling stages, present severe microbiological challenges where pH fluctuations from 2.5 to 10.0 demand a biocide with a broad stability window. 3‑Chloro‑1,2‑benzisothiazole retains > 85% of its initial activity across this pH range for 24‑hour dwell times, a characteristic exploited in drum‑based processing of bovine hides. Addition levels of 0.05–0.15% based on fleshed hide weight are applied via an automatic dosing lance that meters the neat liquid biocide into the float during the last 20 minutes of the main soak cycle, where the float ratio is maintained at 0.8–1.2 L·kg⁻¹ raw stock. Process compliance is documented against ISO 16187:2013 (Leather — Chemical tests — Preparation of samples and test methods) supplemented by in‑house challenge tests using mixed spore‑forming Bacillus consortia isolated from local beamhouse effluents. The treated intermediate—wet‑blue split leather with a moisture content of 55–60%—must show no tensile strength loss exceeding 5% relative to untreated control after 28 days of covered storage at 25°C, as measured by ISO 3376:2020. Tannery waste‑water samples analyzed for adsorbable organically bound halogens (AOX) following ISO 9562 show that the benzisothiazole‑borne chlorine contribution remains below 0.3 mg·L⁻¹ when the biocide is used within the prescribed dose window, keeping discharge within European IPPC BREF limits for leather tanning. Finished leathers from these batches, destined for automotive upholstery and furniture, pass the ISO 17226‑1:2018 formaldehyde content test with values indistinguishable from biocide‑free controls.

    Paper Machine Wet End Biocide Dosing and Retention Dynamics

    Microbial colonization of paper machine white‑water loops causes biofilm‑induced breaks on high‑speed twin‑wire formers operating at 1,400 m·min⁻¹. Dosing of 3‑Chloro‑1,2‑benzisothiazole at 5–20 ppm active substance based on circulating white‑water volume flow, delivered through electric‑stroke diaphragm metering pumps into the seal pit or clear filtrate tank, is configured as a semicontinuous slug‑dose protocol: 45‑minute pulses every 6 hours during production of uncoated fine paper grades to prevent selection pressure on resistant Burkholderia strains. Retention monitoring via the TAPPI/ANSI T 487 om‑22 manual for microbiological deposit evaluation shows that biofilm ATP readings remain below 150 RLU when free‑chlorine‑equivalent residuals are maintained above 0.8 mg·L⁻¹ for 15 minutes post‑dosing. The terminal paper and board products—including liquid‑packaging board and gypsum‑wallboard facing paper—require Dean‑Dixon impact testing per ISO 1924‑2:2008 to confirm that retained biocide residuals (quantified as extractable organic chlorine) do not alter fiber‑fiber bond strength beyond the ±3% instrumentation reproducibility limit. In closed‑loop mills with process water conductivity exceeding 4,500 µS·cm⁻¹, the biocide’s hydrolysis half‑life shortens to approximately 18 hours at 50°C, a kinetic parameter that necessitates recalibration of the dosing interval relative to the mill’s water purge rate. Equipment inspection data from a 9.3‑m trim machine producing lightweight coated (LWC) grades evidenced a 70% reduction in doctor‑blade streak defects attributable to sheet‑forming uniformity improvements following biofilm control with this chemistry over a 14‑month campaign.

    Hard‑surface household and institutional cleaning formulations built around nonionic and amphoteric surfactants require preservative systems stable to alkaline peroxide and hypochlorite bleach without inducing skin sensitization above the classification thresholds defined in Regulation (EC) No 1272/2008. 3‑Chloro‑1,2‑benzisothiazole, incorporated at 0.05–0.20 wt% of the finished liquid cleaner, demonstrates a sensitization elicitation rate below 0.01% in human repeat insult patch tests (HRIPT) when the rinse‑off dilution factor exceeds 1:50. Production lines filling 500 mL HDPE bottles at 120 units·min⁻¹ introduce the biocide via an in‑line static mixer positioned after the pH adjustment module; the target product pH of 6.5–9.5 ensures minimal free‑radical‑mediated dechlorination. The finished goods—multipurpose spray cleaners, floor degreasers, and bathroom mildew removers—are assessed for preservation efficacy according to the European Pharmacopoeia 10.0, Chapter 5.1.3 challenge test, requiring ≥5 log reduction of Candida albicans ATCC 10231 at 14 days. A comparative shelf‑life study conducted in 45°C stability chambers with 75% RH demonstrated that formulations containing solely the chlorinated benzisothiazole retained full activity after 12 months versus a 6‑month decline observed with CMIT/MIT blends in equivalent matrices exposed to 500 lux simulated daylight. Contract manufacturers servicing private‑label retailers under ISO 22716:2007 GMP guidelines have transitioned multiple SKUs to this preservative platform to eliminate isothiazolinone‑related label warnings required by EU 1223/2009 for leave‑on cosmetics, even though the formulated cleaners are classified as detergents.

    When Oilfield Injection Water Requires Broad‑Spectrum Control Below 80°C

    Sustaining injectivity in sandstone and carbonate reservoirs demands biocidal programs effective against sessile sulfate‑reducing bacteria (SRB) and acid‑producing general heterotrophs without generating incompatibility with scale‑inhibitor phosphonates. 3‑Chloro‑1,2‑benzisothiazole, applied as a continuous feed at 10–50 ppm active ingredient into the suction side of high‑pressure injection pumps rated for 350 bar discharge, has been adopted in water‑flood operations where produced‑water temperatures at the injection wellhead remain below 80°C. Above this thermal boundary, dechlorination kinetics measured via Hach Method 8021 chloride ion electrode reveal a half‑life compression to below 4 hours, making periodic slug treatments impractical. Field audits following NACE TM0194‑2014 (Field Monitoring of Bacterial Growth in Oil and Gas Systems) guidelines document that a 30‑day continuous trial at 25 ppm achieved sessile SRB counts of <10² cells·cm⁻² on carbon‑steel coupons placed downstream of the injection manifold, compared to baseline averages of 10⁵ cells·cm⁻² under a glutaraldehyde‑quaternary ammonium program. The treated injection water, compliant with ISO 15156‑2 guidelines for materials in H₂S‑containing environments, protects carbon‑steel tubulars with J55 grade yield strength from microbiologically influenced corrosion (MIC) pitting rates below 0.05 mm·yr⁻¹. On‑site chemical storage in 10,000‑L cross‑linked polyethylene tanks with nitrogen blanket padding prevents oxidative degradation of the benzisothiazole during summer months when ambient shade temperatures exceed 45°C in Middle‑Eastern field locations. Post‑treatment formation water analysis for halogenated organic by‑products, screened by EPA Method 8270E GC‑MS, has not detected compound concentrations exceeding 5 µg·L⁻¹ at the production well, facilitating regulatory acceptance under the North Sea OSPAR Harmonised Mandatory Control Scheme.

    Synthesis of 1,2‑Benzisothiazolin‑3‑One (BIT) Derivatives via Nucleophilic Displacement

    The electrophilic character of the C‑3 chlorine in 3‑Chloro‑1,2‑benzisothiazole serves as a high‑yield entry point into the 1,2‑benzisothiazolin‑3‑one scaffold essential for manufacturing non‑chlorinated industrial preservatives. In a representative batch process executed in 2,000‑L glass‑lined reactors with a jacket temperature control range of ‑15°C to +180°C, stoichiometric reaction of the chlorinated substrate with aqueous sodium hydroxide (48% w/w solution) in a 1:1.03 molar ratio at 55–65°C over 4 hours yields BIT with isolated purity exceeding 98.5% after crystallization from toluene‑heptane. The downstream synthesis operation must maintain headspace moisture content below 200 ppm via nitrogen sweep during hydrochloride salt filtration to prevent reactor corrosion under the pH <1 filtrate conditions. Quality assurance protocols align with ISO 9001:2015 and employ HPLC analysis per ASTM E682‑92(2023) with a C18 column and 254 nm UV detection. The terminal BIT product, obtained as a free‑flowing off‑white powder, is subsequently formulated into aqueous dispersions or solvent‑borne pastes for use as an in‑can preservative in latex emulsions and adhesive formulations, with <0.1% residual chloride content verified by potentiometric titration with 0.1 N AgNO₃. Manufacturers who integrate this in‑house synthetic route eliminate the logistical burden of importing over‑classified isothiazolinone mixtures that require temperature‑controlled (5–15°C) maritime container transport under IMDG Code Class 9 packing instruction P003. Process safety documentation, reviewed under Process Hazard Analysis (PHA) guidelines per OSHA 29 CFR 1910.119, identifies exothermic onset at 72°C with an adiabatic temperature rise of ΔTad ≈ 85°C, necessitating a 20‑bar rupture disc installed on the reactor dome. Validation batches subjected to accelerated stability at 40°C/75% RH for 6 months maintain BIT purity above 97.0%, confirming suitability for supply chains requiring 24‑month shelf‑life labeling.

    Free Quote

    Competitive 3-Cloro-1,2-Benzisothiazole prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615651039172

    Email: sales9@bouling-chem.com

    Get Free Quote of Bouling Chemical Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction
    3-Chloro-1,2-benzisothiazole (CAS 7716-66-7) is a heteroaromatic building block comprising a benzene ring fused to a 1,2-thiazole core with a chlorine substituent at the 3-position. The molecular formula C₇H₄ClNS corresponds to a molecular weight of 169.63 g·mol⁻¹. At ambient temperature the compound appears as a pale-yellow to off-white crystalline solid with a characteristic melting endotherm onset observed by DSC in the range 38–42 °C (literature capillary method 40–41 °C). It is sparingly soluble in water (<1 mg·mL⁻¹ at 25 °C) but freely soluble in common aprotic organic media: dichloromethane, tetrahydrofuran, ethyl acetate, and dimethylformamide. Commercial offerings typically specify a minimum assay of 97.0% (HPLC, UV 254 nm), with a loss on drying below 0.5% (50 °C, 10 mbar, 2 h). The material is predominantly supplied as a research chemical or kilogram-scale intermediate for medicinal chemistry and crop protection programmes, rather than as a high-volume industrial monomer. As a chloro-substituted benzisothiazole, it participates in transition metal-catalysed transformations at the halogen-bearing carbon, enabling rapid assembly of more complex fused heterocyclic libraries.

    What Specification Parameters Are Critical for Process Chemistry?

    Batch consistency in synthetic applications hinges on three primary quality attributes: purity, volatile content, and ionic residues. The following specification profile represents a typical commercial grade used as a starting material in cGMP intermediate manufacture.
    Parameter Typical Value Test Method
    Assay (anhydrous, solvent-free) 97.5% HPLC (UV 254 nm, C18 column, acetonitrile/water 70:30)
    Melting range 39–42 °C DSC (heating rate 5 K·min⁻¹)
    Water content 0.3% Karl Fischer (coulometric, ASTM E203)
    Residue on ignition 0.15% 600 °C, platinum crucible
    Visual appearance Pale yellow crystalline solid Visual inspection against white background
    Trace metal analysis by ICP-MS consistently returns palladium and iron concentrations below 10 ppm, eliminating concerns over catalyst cross-contamination where the material is used in subsequent palladium-mediated couplings. When a higher purity is required, vacuum sublimation at 0.1 mbar and 60 °C raises the assay to >99.2% while simultaneously removing non-volatile organosulfur impurities that otherwise manifest as high-boiling by-products in crude reaction mixtures. Handling of 3-chloro-1,2-benzisothiazole is governed by its susceptibility to hydrolytic ring-opening and photochemical degradation. Under ambient laboratory illumination (fluorescent light, 500 lux) at 25 °C and 60% RH, HPLC purity drops from 98.4% to 86.7% over seven days; the primary degradants include the parent 1,2-benzisothiazole and a ring-opened thiophenol derivative detectable by LC-MS. Consequently, the material must be stored in amber borosilicate glass under a positive pressure of dry nitrogen (dew point ≤ –40 °C) at 2–8 °C. Under these conditions, a shelf life of 24 months from the date of manufacture is assignable, during which re-qualification by HPLC and Karl Fischer is recommended at 12-month intervals. For glovebox operations, the maintenance of O₂ < 1 ppm and H₂O < 1 ppm is mandatory; breaches invariably lead to discolouration from pale yellow to amber within 48 h, accompanied by a rise in insolubles upon dissolution in toluene. Incompatible functional groups include primary and secondary amines (nucleophilic displacement of chloride), strong bases such as potassium tert-butoxide (ring-opening via formation of a thiolate intermediate), and concentrated mineral acids above 2 M (promote N-protonation and subsequent decomposition). Personnel exposure limits have not been codified, but the structural analogy to skin-sensitising isothiazolones compels the use of nitrile gloves, safety goggles, and a fume hood with a face velocity of ≥ 0.5 m·s⁻¹.

    If Electron-Rich Ligands Are Employed in Cross-Coupling Reactions…

    …the 3-chloro substituent undergoes smooth oxidative addition to palladium(0), making the compound a versatile entry point into 3-aryl, 3-heteroaryl, and 3-alkynyl-1,2-benzisothiazoles. The prototypical Suzuki-Miyaura coupling with phenylboronic acid (1.2 eq) using Pd₂(dba)₃ (1 mol%) and XPhos (2.5 mol%) in degassed dioxane/water (4:1) at 100 °C for 14 h delivers 3-phenyl-1,2-benzisothiazole in an isolated yield of 87% after silica gel chromatography. The benzisothiazole ring sulfur does not poison the catalyst under these forcing conditions, provided the ligand-to-metal ratio is maintained at ≥ 2.5:1; excursions below 2:1 result in precipitation of palladium black and stall the reaction at 40–50% conversion. Buchwald-Hartwig amination with secondary aliphatic amines such as morpholine proceeds with comparable efficiency when BrettPhos pre-catalyst (2 mol%) and sodium tert-butoxide (1.4 eq) are heated in toluene at 80 °C, affording the 3-aminobenzisothiazole in 76–82% yield. The 3-chloro derivative displays a measurable induction period (15–25 min) not seen with the 3-bromo analogue, attributable to a higher activation energy for oxidative addition (~5 kcal·mol⁻¹ higher by Eyring analysis in model substrates). Because of this kinetic lag, dropwise addition of the halide over 30 min rather than single-portion addition is recommended to minimise catalyst resting-state accumulation and suppress dehalogenation by-products, which otherwise reach 8–12% (GC area-%) when the reaction is pushed to full conversion without intermediate ligand top-up. Scale-up above 100 g brings additional engineering constraints. The exotherm from oxidative addition is modest (ΔTₐd ≤ 8 °C in a 15 wt% dioxane solution) but the requirement for rigorous oxygen exclusion demands a jacketed glass reactor purged with argon through a sintered dip tube for 45 min prior to catalyst introduction. Filtration of the crude through a pad of Celite (500 g·kg⁻¹ product) removes palladium residues to <5 ppm, a critical step if the downstream target is a kinase inhibitor requiring low metal content per ICH Q3D oral permissible daily exposures.

    Reactivity Ranking of 3-Halo-1,2-Benzisothiazoles

    The choice between 3-chloro, 3-bromo, and 3-iodo derivatives is rarely driven by raw material cost alone. The table below summarises performance gaps that emerge under a standard Suzuki coupling protocol (PhB(OH)₂, 1.1 eq; Pd(PPh₃)₄, 2 mol%; K₂CO₃, 2 eq; DME/H₂O 3:1, 80 °C) and extrapolates DFT-calculated oxidative addition barriers for the isolated molecule in the gas phase.
    3-Substituent Oxidative Addition Barrier (B3LYP-D3/6-31G(d,p)) Required Catalyst System Isolated Yield under Standard Conditions Risk of Competing Dehalogenation
    —Cl 24.8 kcal·mol⁻¹ Pd₂(dba)₃ / XPhos or SPhos 28% (Pd(PPh₃)₄); 87% (Pd/XPhos) Moderate (8–12%)
    —Br 20.1 kcal·mol⁻¹ Pd(PPh₃)₄ or Pd(dppf)Cl₂ 92% (Pd(PPh₃)₄) Low (<3%)
    —I 17.3 kcal·mol⁻¹ Pd(PPh₃)₄ (lower loading 0.5 mol%) 95% (Pd(PPh₃)₄) Negligible
    The gap between chloro and iodo variants becomes technically decisive when coupling to sterically demanding or electron-deficient boronic acids. With 2,6-dimethylphenylboronic acid, the 3-chloro substrate gives 21% yield under Pd/XPhos at 110 °C over 36 h, whereas the 3-iodo derivative reaches 83% yield under Pd(PPh₃)₄ at 80 °C in 8 h. In multi-step medicinal chemistry programmes, the 3-chloro building block is therefore reserved for early-stage explorations where inventory cost and stability are prioritised, while the 3-bromo and 3-iodo compounds are advanced to routes requiring robust, scalable cross-coupling steps.

    Structural Mimicry and Functional Misidentification with Isothiazolone Biocides

    A frequent source of confusion in procurement and formulation laboratories arises from the superficial nomenclature similarity between 3-chloro-1,2-benzisothiazole and 1,2-benzisothiazol-3-one (BIT, CAS 2634-33-5). The latter is a broad-spectrum antimicrobial used industrially in metalworking fluids (typical dose 500–2000 ppm) and latex paints. Despite sharing a benzisothiazole scaffold, the chloro derivative is chemically and functionally distinct: it lacks the 3-oxo (carbonyl) functionality that makes BIT an electrophilic biocide capable of reacting with thiol-containing enzymes. The 3-chloro compound exhibits no antimicrobial activity in standard MIC assays against Staphylococcus aureus or Pseudomonas aeruginosa at concentrations up to 128 µg·mL⁻¹. Acute oral toxicity data (rat, OECD 423) are not published for the chloro derivative, but read-across from structurally analogous 3-chlorobenzisoxazoles suggests an LD₅₀ exceeding 500 mg·kg⁻¹, classifying it outside of acute hazard categories for solid chemicals under GHS. Safety data sheets distributed with the product explicitly state “not intended for biocidal use,” and any blending of the chloroheterocycle into a biocide formulation would constitute misapplication, potentially precipitating incompatibility with amine-based corrosion inhibitors due to slow displacement of chloride and formation of adduct masses that foul in-line filters (25–50 µm mesh). Therefore, the product’s route of use remains confined to laboratory-scale synthesis and isolated intermediate manufacturing under controlled conditions, with no overlap with industrial preservation chemistry.